Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Balchem Corporation stock | $154.24

Learn how to easily invest in Balchem Corporation stock.

Balchem Corporation is a specialty chemicals business based in the US. Balchem Corporation shares (BCPC) are listed on the NASDAQ and all prices are listed in US Dollars. Balchem Corporation employs 1,327 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Balchem Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BCPC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Balchem Corporation stock price (NASDAQ: BCPC)

Use our graph to track the performance of BCPC stocks over time.

Balchem Corporation shares at a glance

Information last updated 2021-10-18.
Latest market close$154.24
52-week range$96.82 - $154.84
50-day moving average $144.71
200-day moving average $133.58
Wall St. target price$155.00
PE ratio 54.8982
Dividend yield $0.58 (0.38%)
Earnings per share (TTM) $2.75

Buy Balchem Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Balchem Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Balchem Corporation price performance over time

Historical closes compared with the close of $154.24 from 2021-10-20

1 week (2021-10-14) 0.92%
1 month (2021-09-21) 9.68%
3 months (2021-07-21) 18.48%
6 months (2021-04-21) 26.93%
1 year (2020-10-21) 47.95%
2 years (2019-10-21) 52.64%
3 years (2018-10-19) 53.81%
5 years (2016-10-21) 103.08%

Is Balchem Corporation under- or over-valued?

Valuing Balchem Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Balchem Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Balchem Corporation's P/E ratio

Balchem Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 55x. In other words, Balchem Corporation shares trade at around 55x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Balchem Corporation's PEG ratio

Balchem Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.9426. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Balchem Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Balchem Corporation's EBITDA

Balchem Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $171.3 million.

The EBITDA is a measure of a Balchem Corporation's overall financial performance and is widely used to measure a its profitability.

Balchem Corporation financials

Revenue TTM $743.9 million
Operating margin TTM 16.28%
Gross profit TTM $223.9 million
Return on assets TTM 6.51%
Return on equity TTM 10.81%
Profit margin 12.08%
Book value $26.84
Market capitalisation $4.9 billion

TTM: trailing 12 months

Shorting Balchem Corporation shares

There are currently 553,407 Balchem Corporation shares held short by investors – that's known as Balchem Corporation's "short interest". This figure is 0.4% up from 551,210 last month.

There are a few different ways that this level of interest in shorting Balchem Corporation shares can be evaluated.

Balchem Corporation's "short interest ratio" (SIR)

Balchem Corporation's "short interest ratio" (SIR) is the quantity of Balchem Corporation shares currently shorted divided by the average quantity of Balchem Corporation shares traded daily (recently around 136981.93069307). Balchem Corporation's SIR currently stands at 4.04. In other words for every 100,000 Balchem Corporation shares traded daily on the market, roughly 4040 shares are currently held short.

However Balchem Corporation's short interest can also be evaluated against the total number of Balchem Corporation shares, or, against the total number of tradable Balchem Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Balchem Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Balchem Corporation shares in existence, roughly 20 shares are currently held short) or 0.0172% of the tradable shares (for every 100,000 tradable Balchem Corporation shares, roughly 17 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Balchem Corporation.

Find out more about how you can short Balchem Corporation stock.

Balchem Corporation share dividends


Dividend payout ratio: 16.76% of net profits

Recently Balchem Corporation has paid out, on average, around 16.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.38% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Balchem Corporation shareholders could enjoy a 0.38% return on their shares, in the form of dividend payments. In Balchem Corporation's case, that would currently equate to about $0.58 per share.

While Balchem Corporation's payout ratio might seem low, this can signify that Balchem Corporation is investing more in its future growth.

Balchem Corporation's most recent dividend payout was on 21 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 23 December 2020 (the "ex-dividend date").

Have Balchem Corporation's shares ever split?

Balchem Corporation's shares were split on a 3:2 basis on 20 January 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Balchem Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Balchem Corporation shares which in turn could have impacted Balchem Corporation's share price.

Balchem Corporation share price volatility

Over the last 12 months, Balchem Corporation's shares have ranged in value from as little as $96.821 up to $154.84. A popular way to gauge a stock's volatility is its "beta".

BCPC.US volatility(beta: 0.57)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Balchem Corporation's is 0.5683. This would suggest that Balchem Corporation's shares are less volatile than average (for this exchange).

Balchem Corporation overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices.

Frequently asked questions

What percentage of Balchem Corporation is owned by insiders or institutions?
Currently 0.8% of Balchem Corporation shares are held by insiders and 89.861% by institutions.
How many people work for Balchem Corporation?
Latest data suggests 1,327 work at Balchem Corporation.
When does the fiscal year end for Balchem Corporation?
Balchem Corporation's fiscal year ends in December.
Where is Balchem Corporation based?
Balchem Corporation's address is: 52 Sunrise Park Road, New Hampton, NY, United States, 10958
What is Balchem Corporation's ISIN number?
Balchem Corporation's international securities identification number is: US0576652004
What is Balchem Corporation's CUSIP number?
Balchem Corporation's Committee on Uniform Securities Identification Procedures number is: 057665200

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site